Analysis reports / SIC major group
SIC Major Group 38 financial report
SIC major group. Companies: 81. Companies with financial data: 81. Companies with revenue: 80. As of: 2026-05-29.
Mechanical ranking by stated metric from SEC/FRED data; not a recommendation, endorsement, or quality/investment judgment.
Chart
Distribution Summary
| Metric | Count | Median | Minimum | Maximum | Min-Max range |
|---|
| Net margin | 79 | 11.51% | -59.09% | 33.41% | 92.50% |
| Operating margin | 78 | 14.84% | -88.00% | 32.75% | 120.75% |
| Revenue growth | 76 | 7.10% | -7.89% | 37.13% | 45.03% |
Highest reported net margin
| Rank | Company | Net margin | FY | Extra |
|---|
| 1 | KLAC - KLA CORP | 33.41% | 2025 | |
| 2 | TMDX - TransMedics Group, Inc. | 31.43% | 2025 | |
| 3 | BIO - BIO-RAD LABORATORIES, INC. | 29.42% | 2025 | |
| 4 | ISRG - INTUITIVE SURGICAL INC | 28.38% | 2025 | |
| 5 | RMD - RESMED INC | 27.22% | 2025 | |
| 6 | LMAT - LEMAITRE VASCULAR INC | 23.13% | 2025 | |
| 7 | GRMN - GARMIN LTD | 22.96% | 2025 | |
| 8 | MTD - METTLER TOLEDO INTERNATIONAL INC/ | 21.59% | 2025 | |
| 9 | WAT - WATERS CORP /DE/ | 20.30% | 2025 | |
| 10 | AME - AMETEK INC/ | 20.00% | 2025 | |
Lowest reported net margin
| Rank | Company | Net margin | FY | Extra |
|---|
| 1 | RAL - Ralliant Corp | -59.09% | 2025 | |
| 2 | ENOV - Enovis CORP | -52.69% | 2025 | |
| 3 | TFX - TELEFLEX INC | -45.45% | 2025 | |
| 4 | GKOS - GLAUKOS Corp | -36.99% | 2025 | |
| 5 | STAA - STAAR SURGICAL CO | -33.60% | 2026 | |
| 6 | CTKB - Cytek Biosciences, Inc. | -33.02% | 2025 | |
| 7 | IART - INTEGRA LIFESCIENCES HOLDINGS CORP | -31.58% | 2025 | |
| 8 | TNDM - TANDEM DIABETES CARE INC | -20.17% | 2025 | |
| 9 | LIVN - LivaNova PLC | -17.47% | 2025 | |
| 10 | COHU - COHU INC | -16.40% | 2025 | |
Highest reported operating margin
| Rank | Company | Operating margin | FY | Extra |
|---|
| 1 | RMD - RESMED INC | 32.75% | 2025 | |
| 2 | ISRG - INTUITIVE SURGICAL INC | 29.27% | 2025 | |
| 3 | ROP - ROPER TECHNOLOGIES INC | 28.29% | 2025 | |
| 4 | LMAT - LEMAITRE VASCULAR INC | 27.21% | 2025 | |
| 5 | SOLV - Solventum Corp | 26.20% | 2025 | |
| 6 | GRMN - GARMIN LTD | 25.89% | 2025 | |
| 7 | AME - AMETEK INC/ | 25.81% | 2025 | |
| 8 | WAT - WATERS CORP /DE/ | 25.36% | 2025 | |
| 9 | VLTO - Veralto Corp | 23.21% | 2025 | |
| 10 | EMBC - Embecta Corp. | 22.41% | 2025 | |
Lowest reported operating margin
| Rank | Company | Operating margin | FY | Extra |
|---|
| 1 | BAX - BAXTER INTERNATIONAL INC | -88.00% | 2025 | |
| 2 | RAL - Ralliant Corp | -57.18% | 2025 | |
| 3 | ENOV - Enovis CORP | -50.01% | 2025 | |
| 4 | GKOS - GLAUKOS Corp | -39.33% | 2025 | |
| 5 | STAA - STAAR SURGICAL CO | -38.30% | 2026 | |
| 6 | IART - INTEGRA LIFESCIENCES HOLDINGS CORP | -30.17% | 2025 | |
| 7 | CTKB - Cytek Biosciences, Inc. | -20.04% | 2025 | |
| 8 | TNDM - TANDEM DIABETES CARE INC | -18.45% | 2025 | |
| 9 | BLFS - BIOLIFE SOLUTIONS INC | -17.26% | 2025 | |
| 10 | COHU - COHU INC | -15.40% | 2025 | |
Largest reported revenue growth
| Rank | Company | Revenue growth | FY | Extra |
|---|
| 1 | TMDX - TransMedics Group, Inc. | 37.13% | 2025 | |
| 2 | GKOS - GLAUKOS Corp | 32.33% | 2025 | |
| 3 | PODD - INSULET CORP | 30.73% | 2025 | |
| 4 | BLFS - BIOLIFE SOLUTIONS INC | 28.89% | 2025 | |
| 5 | KLAC - KLA CORP | 23.89% | 2025 | |
| 6 | COHR - COHERENT CORP. | 23.42% | 2025 | |
| 7 | ISRG - INTUITIVE SURGICAL INC | 20.51% | 2025 | |
| 8 | BSX - BOSTON SCIENTIFIC CORP | 19.87% | 2025 | |
| 9 | UFPT - UFP TECHNOLOGIES INC | 19.50% | 2025 | |
| 10 | PEN - Penumbra Inc | 17.50% | 2025 | |
Informational only - not investment advice.